Comments on the Klerman-Stone debate on Osheroff v. Chestnut Lodge.
D000928:Antidepressive Agents / Q000627:therapeutic use; D001689:Biological Psychiatry / Q000592:standards; D003131:Combined Modality Therapy; D003866:Depressive Disorder / Q000188:drug therapy / Q000628:therapy; D005104:Expert Testimony; D005260:Female; D006801:Humans; D008318:Malpractice / Q000331:legislation & jurisprudence*; D008396:Maryland; D001523:Mental Disorders / Q000188:drug therapy / Q000628:therapy*; D008875:Middle Aged; D010344:Patient Advocacy / Q000331:legislation & jurisprudence; D011570:Psychiatry / Q000592:standards*; D011575:Psychoanalytic Therapy / Q000592:standards; D011613:Psychotherapy / Q000592:standards; D014481:United States
D000928:Antidepressive Agents